These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8728689)

  • 1. Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.
    Gregory H; Schofield A; de Silva D; Semper J; Milner B; Allan L; Haites N
    J Med Genet; 1996 Mar; 33(3):187-92. PubMed ID: 8728689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 gene testing for breast and ovarian cancer in one family.
    Crosbie A; Brewer C; Campbell K; MacKay J
    Br J Nurs; 1998 Dec 10-1999 Jan 13; 7(22):1386-92. PubMed ID: 10076219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
    Hartenbach EM; Becker JM; Grosen EA; Bailey HH; Petereit DG; Laxova R; Schink JC
    Genet Test; 2002; 6(2):75-8. PubMed ID: 12229876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
    Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of population-based studies in assessing genetic cancer risk.
    Berry DA
    J Natl Cancer Inst; 2001 Aug; 93(16):1188-9. PubMed ID: 11504754
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic counseling in familial breast cancer].
    Pichert G
    Ther Umsch; 2008 Apr; 65(4):235-41. PubMed ID: 18622917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial breast cancer.
    Steel CM; Cohen BB; Porter DE
    Semin Cancer Biol; 1992 Jun; 3(3):141-50. PubMed ID: 1511156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.
    Brunsvold AN; Wung SF; Merkle CJ
    J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
    Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
    J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for the familial breast/ovarian cancer gene.
    Black DM; Solomon E
    Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.
    Sinilnikova OM; Mazoyer S; Bonnardel C; Lynch HT; Narod SA; Lenoir GM
    Fam Cancer; 2006; 5(1):15-20. PubMed ID: 16528604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of breast and ovarian cancer in women with strong family histories.
    Srivastava A; McKinnon W; Wood ME
    Oncology (Williston Park); 2001 Jul; 15(7):889-902; discussion 902, 905-7, 911-13. PubMed ID: 11499690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast & ovarian cancer. Issues in risk assessment.
    Caro SW
    Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.